Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.
Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check5 days agoChange DetectedRevision tag at the bottom of the page updated from v3.5.3 to v3.5.4.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page reflects small non-study informational updates, including resource/glossary labeling and a software/version revision change from v3.5.2 to v3.5.3. No substantive changes to the trial’s core study content (like eligibility criteria, interventions, or outcome measures) are indicated.SummaryDifference0.2%
- Check34 days agoChange DetectedA new revision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%
- Check55 days agoChange DetectedRemoved non-core items: the term 'Interstitial lung disease 2' and the Genetics and Rare Diseases Information Center resource link. These deletions do not affect the study's main data, eligibility criteria, or reported results.SummaryDifference0.2%
- Check63 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0, indicating an update to the document set.SummaryDifference0.1%
- Check70 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%
Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.